Documents
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Haddock, Miller, Olivier, Barney
Documents
Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma
Höblinger A, Gerhardt T, González-Carmona Ma, Hüneburg R, Sauerbruch T, Schmitz V, Schmitz
Documents
Tumor markers as a diagnostic key for hilar Cholangiocarcinoma
Juntermanns B, Radunz S, Heuer M, Hertel S, Reis H, Neuhaus Jp, Vernadakis S, Trarbach T, Kaiser Gm, Paula, Kaiser
Documents
The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1
Radwan, Ahmed
Documents
Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
Hajósi-Kalcakosz Szofia, Dezså‘ Katalin, Bugyik Edina, Bödör Csaba, Paku Sándor, Pávai Zoltán, Halász Judit, Schlachter Krisztina, Schaff Zsuzsa, Nagy Péter, Nagy
Documents
Savoirs
Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
Hajósi-Kalcakosz Szofia, Dezså‘ Katalin, Bugyik Edina, Bödör Csaba, Paku Sándor, Pávai Zoltán, Halász Judit, Schlachter Krisztina, Schaff Zsuzsa, Nagy Péter, Nagy
7 pages
English
Documents
Correlation between promoter methylation of p14ARF, TMS1/ASC, and DAPK, and p53mutation with prognosis in cholangiocarcinoma
Xiaofang Liu, Kun Tang, Shaoping Yu, Zaiqiu Wang, Hailong, Hailong Su
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
{{productCategoryLabel}}
{{productTitle}}
{{productAuthors}}
{{productCategoryLabel}}
{{productThemeLabel}}
{{productTitle}}
{{productAuthors}}
{{productPages}}
{{productLanguageIsoCode}}